Slate Path Capital LP - 30 Jun 2025 SCHEDULE 13G Report for Tvardi Therapeutics, Inc. Common stock, par value $0.001 per share (TVRD)

Filing Manager: Slate Path Capital LP
Reporting Manager: Slate Path Capital LP
Security: Tvardi Therapeutics, Inc. Common stock, par value $0.001 per share
Symbol: TVRD
Shares outstanding: 9.39M shares
Disclosed Ownership: 704K shares
Ownership: 7.5%
Form type: SCHEDULE 13G
Filing time: 14 Aug 2025, 16:15:31 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Slate Path Capital LP	7.5%	704K	0	704K	/s/ Thomas Hansen	By: Jades GP, LLC, General Partner, By: Thomas Hansen, Chief Financial Officer and Chief Operating Officer
David Greenspan	7.5%	704K	0	704K	/s/ Jim Feeney	Jim Feeney, Attorney-In-Fact*